Synergy of EGFR and AURKA Inhibitors in <i>KRAS</i> -mutated Non–small Cell Lung Cancers
Tetyana Bagnyukova(Fox Chase Cancer Center), Hossein Borghaei(Fox Chase Cancer Center)
Cited by 13
Related Papers
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227
|Journal of Clinical Oncology|2022|375
DUSP6 regulates drug sensitivity by modulating DNA damage response
|British Journal of Cancer|2013|37
<i>NRG1</i> fusions in solid tumors.
|Journal of Clinical Oncology|2023|7